GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Margin of Safety % (DCF Earnings Based)

Beijing Tiantan Biological Products (SHSE:600161) Margin of Safety % (DCF Earnings Based) : -123.91% (As of Jun. 10, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-06-10), Beijing Tiantan Biological Products's Predictability Rank is 4-Stars. Beijing Tiantan Biological Products's intrinsic value calculated from the Discounted Earnings model is ¥13.93 and current share price is ¥31.19. Consequently,

Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -123.91%.

Competitive Comparison of Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) falls into.


Beijing Tiantan Biological Products Margin of Safety % (DCF Earnings Based) Calculation

Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(13.93-31.19)/13.93
=-123.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

Beijing Tiantan Biological Products Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
SZSE:002252 SZSE:300759 SZSE:002653 SZSE:002007 SZSE:301301 SZSE:002821 SHSE:688578 SHSE:603233 SHSE:688278 SHSE:688520 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Website
http://www.tiantanbio.com
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Executives
Wang Jian Ming Supervisors
Liu Ya Na Directors, senior managers
Fu Dao Xing Directors, senior managers
He Yan Lin Directors, senior managers
Hu Li Gang Director
Ci Xiang senior management
Yang Hui Chuan Director
Zhang Yi senior management
Wu Zhen Shan senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines